All In Biotech

Drug Trial Radar · NCT03028350

Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)

A Phase 2 Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to Evaluate Oral Ifetroban in Subjects With Symptomatic Aspirin Exacerbated Respiratory Disease (AERD)

Last checked: Nov 19, 2026Latest source record: Jul 10, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

54

Actual

Start

Jul 17, 2017

Primary completion

Apr 25, 2023

Study completion Apr 25, 2023

Sponsor

Lead sponsor
Cumberland PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Jan 23, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this phase 2 study is to assess the safety and efficacy of oral ifetroban for the treatment of aspirin-exacerbated respiratory disease (AERD). AERD is a disease that involves asthma, recurring nasal polyps, and respiratory reactions to aspirin and other nonsteroidal anti-inflammatory drugs.

Conditions

  • Asthma, Aspirin-Induced

Interventions

  • Ifetroban Oral CapsuleDrug

    Subjects will be treated with oral ifetroban daily for 8 weeks

  • Placebo Oral CapsuleDrug

    Subjects will be treated with oral placebo daily for 8 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Sinonasal Outcome Test-22 ScoreTime frame: Baseline and 8 weeks

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Banner University of Arizona Medical Center, Asthma & Airway Disease Research Center

    Tucson, Arizona

  • Antelope Valley Clinical Trials

    Lancaster, California

  • Scripps Clinic - Carmel Valley

    San Diego, California

  • Stanford University Medical Center

    Stanford, California

  • The Research Center

    Hialeah, Florida

  • Emory University School of Medicine, Sinus, Nasal, and Allergy Center

    Atlanta, Georgia

  • Deaconess Clinic

    Evansville, Indiana

  • Kansas City Allergy and Asthma Associates, PA

    Overland Park, Kansas

  • Advanced ENT & Allergy

    Louisville, Kentucky

  • Rochester Regional Health

    Rochester, New York

  • Montefiore Medical Center

    The Bronx, New York

  • Wake Forest Baptist Health

    Winston-Salem, North Carolina

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • UT Southwestern Medical Center

    Dallas, Texas

  • University of Virginia Medical Center

    Charlottesville, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.